Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2016 Volume 12 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2016 Volume 12 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis

  • Authors:
    • Zhongwei Li
    • Naikun Li
    • Yanyan Qu
    • Feng Gai
    • Guowei Zhang
    • Guanghui Zhang
  • View Affiliations / Copyright

    Affiliations: CT Room, Yantaishan Hospital, Yantai, Shandong 264001, P.R. China, Department of Medical Imaging, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China, Department of Endocrinology, Yantaishan Hospital, Yantai, Shandong 264001, P.R. China, Department of Radiology, Yantai Municipal Laiyang Central Hospital, Yantai, Shandong 265200, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 297-301
    |
    Published online on: May 9, 2016
       https://doi.org/10.3892/etm.2016.3318
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The application value of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis was evaluated. A total of 58 cases of transient ischemic attack (TIA) and 60 cases of ischemic cerebral apoplexy cases were selected. The cases were analysed using a GE Healthcare Signa HDx 3.0T superconducting whole‑body magnetic resonance scan within 24 h of attack. Eight‑channel head phased array coils and conventional sequence were used to create T1‑weighted images (T1WI), T2WI, diffusion‑weighted imaging, magnetic resonance angiography (MRA) and ASL imaging, which were generated into ASL pseudo‑color images (blue was hypoperfusion area) through post-processing in order to compare and analyze the correlation and differences between ASL and conventional imaging in terms of lesion location, size, blood perfusion situation and signal range of relative cerebral blood flow (rCBF). The results showed that, 13 TIA cases of abnormal signal in conventional magnetic resonance imaging (MRI) can also be found through ASL technology. Diameter stenosis beyond 30% in MRA can also be tested in ASL. A positive rate in ASL was significantly higher than that of conventional MRI (χ2=29.078, P<0.001) and hypoperfusion area was greatly increased (t=32.526, P<0.001). The rCBF value was positively correlated with the degree of diameter stenosis shown in MRA (r=0.524, P=0.012). Additionally, the positive rate of ASL was positively correlated with the attack times of TIA (r=0.352, P=0.027). A total of 39 cerebral apoplexy cases of abnormal signal in conventional MRI were also found through ASL technology. A positive rate in ASL was significantly higher than that of conventional MRI (χ2=7.685, P=0.006) and hypoperfusion area was greatly increased (t=9.425, P<0.001). The rCBF value was positively correlated with the degree of diameter stenosis (r=0.635, P=0.009). In conclusion, 3.0T ASL correlated with early diagnosis of TIA and mild and moderate intracranial arterial stenosis of cerebral apoplexy.

Introduction

Ischemic cerebral apoplexy is a worldwide. It is reported that the prevalence of ischemic stroke is 20–40% with a high disability rate (60–85%) and high mortality rate (30–45%) for individuals over the age of 40 years (1) It is believed that multiple factors result in the temporary or permanent ischemia of the artery. Furthermore, there are a series of secondary mechanisms of brain tissue and cells e.g., ischemic/hypoxic injury, energy metabolic disorder, oxidative stress and calcium overload (2). Approximately 50–65% patients have transient ischemic attack (TIA), which may be a different development process for another disease compared with cerebral apoplexy, but they have the same pathological basis i.e., stenosis of feeding artery (3). Early diagnosis of the target vessel lesion was significant in terms of improving the clinical remedy rate and life quality. Conventional magnetic resonance imaging (MRI) has a resolution ratio on components of brain tissue, but also has poor results on showing blood flow perfusion (4). Dynamic magnetic sensitivity contrast agent perfusion-weighted imaging (PWI) increases complications and counterfeit image interference from exogenous contrast agents (5). Magnetic resonance angiography (MRA) has unsatisfactory development on small artery lesions, small and moderate artery with mild or no obvious stenosis (6). It cannot provide accurate imaging information in time. Cerebral blood flow (CBF) imaging, which is obtained through using free water proton in arterial blood as an endogenous tracer and reverse pulse technology for labeling and then post-processing, is able to sensitively and specifically indicate abnormal changes of cerebral perfusion (7). It has been approved to different degrees for ischemic and hemorrhagic cerebrovascular diseases, and has better developing effects compared with conventional diffusion-weighted imaging (DWI), PWI and functional MRI, and also better signal-to-noise ratio (SNR), high repeatability and consensus stability (8).

The present study examined the application value of arterial spin labeling (ASL) in TIA and mild and moderate intracranial atherosclerotic stenosis, which provide references for the early recognition of target lesions and immediate treatment clinically.

Patients and methods

Patients

A total of 58 cases of TIA and 60 cases of ischemic cerebral apoplexy were diagnosed at the Yantaishan Hospital (Shandong, China) and were selected between January 2014 and January 2016. These cases were 32 men and 26 women in the TIA group, with an average age of 45.6±10.3 years. The average onset time of disease was 1.5±0.4 min, and the average number of attack times was 1.5±0.6. There were 12 hypertensive, 8 smoking, 5 diabetic and 7 hyperlipidaemic cases. In the cerebral apoplexy group, there were 36 male and 34 female cases, with an average age of 47.7±11.5 years, an average onset time of disease of 26.4±7.2 min, and an average number of attack times of 1.3±0.5. There were 32 cases with lesion location at basal ganglia region, 14 cases at cerebrum, 7 cases at cerebellum and 7 cases at brainstem.. There were 15 hypertensive, 10 smoking, 3 diabetic and 5 hyperlipidaemic cases. There was no statistical differences between the two groups regarding gender, age, attack times and combined disease type (P>0.05).

Infored consent was obtained from the patients and their family members. Approval for the study was obtained by the ethics committee of Yantaishan Hospital.

Study method

GE Healthcare Signa HDx 3.0T (GE Healthcare, Piscataway, NJ, USA) superconducting whole-body magnetic resonance scan was performed on all the patients within 24 h of attack. The maximum uniaxial gradient strength was ≥45 mT/m. Eight-channel head phased array coils and conventional sequence were used to obtain T1-weighted images (T1WI), T2WI, DWI, MRA and ASL imaging. The scanning parameters were OAxT1WI: TR=1,750 msec, TE=24 msec, number of layers was 20, thickness of layer was 5.0 mm, spacing between layers was 1.0 mm, vision FOV: 22×22 cm, NEX was 1 and matrix was 320×224. OAxT2WI: TR=5,100 msec, TE=118.9 msec, number of layers was 20, thickness of layer was 5.0 mm, spacing between layers was 1.0 mm, FOV: 22×22 cm, NEX was 1.5 and matrix was 512×512. DWI: TR=5,400 msec, TE=minimum, number of layers were 20, thickness of layer was 5.0 mm, spacing between layers was 1.0 mm, vision FOV: 22×22 cm and NEX was 1. MRA selected three-dimensional time-of-flight method and TR=40 msec, TE=8 msec, number of layers was 20, thickness of layer was 5.0 mm, spacing between layers was 1.0 mm, vision FOV: 22×22 cm and NEX was 1. Intracranial vascular examination included intracranial artery (intracalvarium, siphon bend and terminal segment), middle cerebral artery M1–3 segments and anterior cerebral artery A1–3 segments.

For ASL technology, FAIR was used and TR=1,000 msec, TE=13.8 msec, TI=2,000 msec, number of layers was 20, thickness of layer was 1.3 mm, spacing between layers was 1.0 mm, vision FOV: 22×22 cm, NEX was 80, matrix was 256×128 and scanning time was 2 min and 48 sec. Scanning was performed at the plane of 1 cm above the corpus callosum, because this area was supplied with blood from the anterior cerebral and middle cerebral arteries, and therefore was less influenced by magnetic sensitivity or vein pollution. Reconstruction of ASL imaging was shown in pseudo color map, where the red area was high perfusion, green was moderate perfusion and blue was low perfusion. A qualitative and semiquantitative analysis on ASL imaging was performed and the corresponding value of relative CBF (rCBF) was used to distinguish perfusion, where rCBF <0.9 referred to low perfusion, 0.9–1.1 was moderate perfusion and >1.1 high perfusion. Two experienced MRI doctors jointly observed the distribution of grey and white matter, and subsequently confirmed the abnormal area of perfusion and determined the lesion location based on clinical manifestations of TIA. The doctors manually drew the region of interest (ROI) for grey and white matter of abnormal perfusion. RESTplus 1.1 software (RESTplus, Hangzhou, China; http://restfmri.net/forum/index.php?q=rest) was used to manually test ROI was used to manually test ROI signal strength, and the image method was used to place ROI at the other side to measure signal strength of the corresponding side and perform semiquantitative analysis. The average signal strength at the abnormal perfusion side was the healthy side, and was considered abnormal if the value was >20%.

Observation index

The correlation and differences between ASL and conventional imaging were compared and analyzed in terms of lesion location, size, blood perfusion and the signal range of rCBF.

Statistical analysis

SPSS 19.0 (SPSS, Inc., Chicago, IL, USA) was used to analyze and process data. Quantitative data were presented as mean value ± standard deviation, where comparisons between groups were made using a t-test. Qualitative data were presented as number of cases, or percentage, and comparisons between groups were made using the χ2 test. Correlation analysis was performed using Pearson's or Spearman's tests. P<0.05 was considered to indicate a statistically significant difference.

Results

Analysis on the development in TIA group

There were 13 cases of an abnormal signal tested in conventional MRI (manifesting as T1 and T2 low signal) and the positive rate was 22.4%. The hypoperfusion area of DWI was 0.5–1.8 mm2 and the average was 1.1±0.6 mm2. The diameter stenosis of intracranial arterial lumen tested in MRA was 10–50% and average was 32.5±10.4%. In ASL, 37 cases with hypoperfusion area were tested (63.8%), the rCBF was 0.6–1.2 and the average was 0.8±0.3. The semiquantitative analysis revealed that the rate of abnormal perfusion signals was 72.4% (42/58), the hypoperfusion area was 1.2–5.4 mm2 and the average was 3.3±1.4 mm2. For the location of the hypoperfusion area, 18 cases were at basal ganglia, 10 cases were at cerebrum, 6 cases were at cerebellum and 3 cases were at brainstem. A total of 13 cases of abnormal signal in conventional MRI were identified through ASL technology. Diameter stenosis beyond 30% in MRA were tested in ASL. A positive rate in ASL was significantly higher than that of conventional MRI (χ2=29.078, P<0.001) and the hypoperfusion area was greatly increased (t=32.526, P<0.001). The rCBF value was positively correlated with the degree of diameter stenosis shown in MRA (r=0.524, P=0.012). Additionally, the positive rate of ASL was positively correlated with the attack times of TIA (r=0.352, P=0.027) (Fig. 1).

Figure 1.

TIA scan (A) T1. (B) T2 with no obvious changes. C) Small ischemic foci at left temporal-occipital junction of DW1. (D) MRA with no obvious arterial luminal stenosis. (E) Hyperfusion area of left temporo-occipital junction of ASL, with area larger than (C). TIA, transient ischemic attack; DW1, diffusion-weighted imaging; MRA, magnetic resonance angiography; ASL, arterial spin labeling.

Analysis on the development in cerebral apoplexy group

There were 39 cases of abnormal signal tested in conventional MRI (manifesting as T1 and T2 low signal) and the positive rate was 65.0%, with a hypoperfusion area of DWI was 1.6–4.5 mm2 and an average was 3.2±1.3 mm2. The diameter stenosis of intracranial arterial lumen tested in MRA was 30–75% and the average was 56.5±14.8%. In ASL, 52 cases had a hypoperfusion area (86.7%), rCBF 0.4–1.0 and an average of 0.6±0.2. The rate of abnormal perfusion signals was 91.7% (55/60), the hypoperfusion area was 1.8–8.5 mm2 and the average was 5.7±1.6 mm2. For the location of the hypoperfusion area, 26 cases were at basal ganglia, 14 cases at cerebrum, 7 cases at cerebellum and 5 cases at brainstem. A total of 39 cases of abnormal signal in the conventional MRI were identified through ASL technology. A positive rate in ASL was significantly higher than that of the conventional MRI (χ2=7.685, P=0.006) and the hypoperfusion area was greatly increased (t=9.425, P<0.001). The rCBF value was positively correlated with the degree of diameter stenosis (r=0.635, P=0.009) (Fig. 2).

Figure 2.

Cerebral apoplexy scan (A) T1. (B) T2, which shows a large area of infarcted focus at right basal ganglia region. (C) DW1 showing high density shadow of the same position. (D) MRA showing absence and interruption of left posterior cerebral artery. (E) ASL, rCBF=0.4, blue color is the hypoperfusion area and the area is larger than that in (C). DW1, diffusion-weighted imaging; MRA, magnetic resonance angiography; ASL, arterial spin labeling.

Discussion

ASL is a non-invasive, safe and simple technology that tests blood perfusion of brain tissue. Decrease or abnormality of brain blood perfusion was the pathological basis of ischemic cerebrovascular disease and the main diagnostic basis. There were corresponding clinical symptoms when whole-brain CBF was <50%, in other words 23 ml/min·100 g (9). ASL technology was used to test the decrease or absence of perfusion in the early period and calculate rCBF, which provided a significant reference value for the quantitative reaction of hemodynamic changes of cerebrovascular diseases as well as clinical diagnosis and treatment (10). Based on different inversion labeling methods for arterial blood, ASL technology was divided into continuous ASL (CASL) and pulsing ASL (PASL). CASL has a higher SNR and narrow labeling plane, its sensitive area of radiofrequency coil need not be long and consequently, it is considered more suitable for a lower anatomical layer (5). However, CASL has a higher radiofrequency energy deposition and its tissue was greatly influenced by the magnetization transfer effect (11). Nevertheless, PASL was able to eliminate the magnetization vector from static structure at the notch pulse and control pulse, which may minimize defective artifacts of profiled outline. In addtion, the inversion labeling rate of PASL is greatly improving (12). With the development of MR software and hardware and increasing investigations of ASL technology, the ASL sequence is also improving continuously, such as FAIREST technology performing the third imaging on imaging layer after saturation based on core sequence (FAIR sequence), which is able to effectively separate blood oxygen level-dependent (BOLD) weight and perform quantitative CBF measurement (13). BOLD and T1-weighted imaging can subsequently be obtained to reflect blood perfusion and metabolic status of brain tissue more accurately (13).

Calamante et al applied CASL technology to examine transient middle cerebral artery occlusion in a rat model (14). The results of that study showed that, ASL can be used to reveal low blood perfusion of cerebral ischemia for animals and monitor the time course of ischemia reperfusion and treatment effects of embolism (14). Chalela et al (15) have previously reported a CASL study with 15 cases of acute ischemic apoplexy patients. The findings of that study showed that CASL is able to identify insufficient perfusion of acute cerebral ischemia and is correlated with clinical symptoms (15). In addition, Bokkers et al (16) used ASL technology to scan 23 cases of carotid artery stenosis (including cases with and without ischemic symptoms) and 20 healthy cases and observed the perfusion of brain tissue prior to and after acetazolamide. The results of those authors showed that the perfusion area of brain tissue for carotid artery stenosis with symptoms was smaller than those with no symptoms (16). After intravenous injection of acetazolamide, cerebral blood perfusion increased, but the increase in scope for carotid artery stenosis with symptoms were lower than that of cases with symptoms, but both of them were lower than those of healthy individuals. The results of that study indicated that ASL was able to test blood perfusion of brain tissue, providing CBF information for cerebral ischemia patients, which was useful in conventional MRI testing.

The 13 cases of abnormal signal in conventional MRI (positive rate 22.4%) were also identified through ASL technology (positive rate 63.8%). Diameter stenosis beyond 30% in MRA was also tested in ASL. The positive rate in ASL was significantly higher than that of conventional MRI and hypoperfusion area was greatly increased. The rCBF value was positively correlated with the degree of diameter stenosis shown in MRA and the positive rate of ASL was positively correlated with the attack times of TIA. A total of 39 abnormal signal cases of cerebral apoplexy in conventional MRI (positive rate 65.0%) were identified through ASL technology (positive rate 86.7%). A positive rate in ASL was significantly higher than that of the conventional MRI and hypoperfusion area was greatly increased. The rCBF value was positively correlated with the degree of diameter stenosis. In conclusion, 3.0T ASL was equally important in the early diagnosis of TIA and mild, moderate intracranial arterial stenosis of cerebral apoplexy.

References

1 

Bu X, Li C, Zhang Y, Xu T, Wang D, Sun Y, Peng H, Xu T, Chen CS, Bazzano LA, Chen J and He J: CATIS Investigators. Early Blood Pressure Reduction in Acute Ischemic Stroke with Various Severities: A subgroup analysis of the CATIS trial. Cerebrovasc Dis. 42:186–195. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Psychogios K, Stathopoulos P, Takis K, Vemmou A, Manios E, Spegos K and Vemmos K: The Pathophysiological Mechanism Is an independent predictor of long-term outcome in stroke patients with large vessel atherosclerosis. J Stroke Cerebrovasc Dis. 24:2580–2587. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Kivikko M, Kuoppamäki M, Soinne L, Sundberg S, Pohjanjousi P, Ellmen J and Roine RO: Oral levosimendan increases cerebral blood flow velocities in patients with a history of stroke or transient ischemic attack: A pilot safety study. Curr Ther Res Clin Exp. 77:46–51. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Snow NJ, Peters S, Borich MR, Shirzad N, Auriat AM, Hayward KS and Boyd LA: A reliability assessment of constrained spherical deconvolution-based diffusion-weighted magnetic resonance imaging in individuals with chronic stroke. J Neurosci Methods. 257:109–120. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Zhang SX, Yao YH, Zhang S, Zhu WJ, Tang XY, Qin YY, Zhao LY, Liu CX and Zhu WZ: Comparative study of DSC-PWI and 3D-ASL in ischemic stroke patients. J Huazhong Univ Sci Technolog Med Sci. 35:923–927. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Eugène F, Gauvrit JY, Ferré JC, Gentric JC, Besseghir A, Ronzière T and Raoult H: One-year MR angiographic and clinical follow-up after intracranial mechanical thrombectomy using a stent retriever device. AJNR Am J Neuroradiol. 36:126–132. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Faraco CC, Strother MK, Dethrage LM, Jordan L, Singer R, Clemmons PF and Donahue MJ: Dual echo vessel-encoded ASL for simultaneous BOLD and CBF reactivity assessment in patients with ischemic cerebrovascular disease. Magn Reson Med. 73:1579–1592. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Nael K, Meshksar A, Liebeskind DS, Wang DJ, Ellingson BM, Salamon N and Villablanca JP: UCLA Stroke investigators: Periprocedural arterial spin labeling and dynamic susceptibility contrast perfusion in detection of cerebral blood flow in patients with acute ischemic syndrome. Stroke. 44:664–670. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Wang DJ, Alger JR, Qiao JX, Gunther M, Pope WB, Saver JL, Salamon N and Liebeskind DS: UCLA Stroke Investigators: Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging. Neuroimage Clin. 3:1–7. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Kaichi Y, Okada G, Takamura M, Toki S, Akiyama Y, Higaki T, Matsubara Y, Okamoto Y, Yamawaki S and Awai K: Changes in the regional cerebral blood flow detected by arterial spin labelingafter 6-week escitalopram treatment for major depressive disorder. J Affect Disord. 194:135–143. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Garraux G, Hallett M and Talagala SL: CASL fMRI of subcortico-cortical perfusion changes during memory-guided finger sequences. Neuroimage. 25:122–132. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Bibic A, Knutsson L, Schmidt A, Henningsson E, Månsson S, Abul-Kasim K, Åkeson J, Gunther M, Ståhlberg F and Wirestam R: Measurement of vascular water transport in human subjects using time-resolved pulsed arterial spin labelling. NMR Biomed. 28:1059–1068. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Guo L, Zhang Q, Ding L, Liu K, Ding K, Jiang C, Liu C, Li K and Cui L: Pseudo-continuous arterial spin labeling quantifies cerebral blood flow in patients with acute ischemic stroke and chronic lacunar stroke. Clin Neurol Neurosurg. 125:229–236. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Calamante F, Thomas DL, Pell GS, Wiersma J and Turner R: Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab. 19:701–735. 1999. View Article : Google Scholar : PubMed/NCBI

15 

Chalela JA, Alsop DC, Gonzalez-Atavales JB, Maldjian JA, Kasner SE and Detre JA: Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke. 31:680–687. 2000. View Article : Google Scholar : PubMed/NCBI

16 

Bokkers RPH, van Osch MJP, van der Worp HB, de Borst GJ, Mali WP and Hendrikse J: Symptomatic carotid artery stenosis: Impairment of cerebral autoregulation measured at the brain tissue level with arterial spin-labeling MR imaging. Radiology. 256:201–208. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Z, Li N, Qu Y, Gai F, Zhang G and Zhang G: Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis. Exp Ther Med 12: 297-301, 2016.
APA
Li, Z., Li, N., Qu, Y., Gai, F., Zhang, G., & Zhang, G. (2016). Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis. Experimental and Therapeutic Medicine, 12, 297-301. https://doi.org/10.3892/etm.2016.3318
MLA
Li, Z., Li, N., Qu, Y., Gai, F., Zhang, G., Zhang, G."Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis". Experimental and Therapeutic Medicine 12.1 (2016): 297-301.
Chicago
Li, Z., Li, N., Qu, Y., Gai, F., Zhang, G., Zhang, G."Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis". Experimental and Therapeutic Medicine 12, no. 1 (2016): 297-301. https://doi.org/10.3892/etm.2016.3318
Copy and paste a formatted citation
x
Spandidos Publications style
Li Z, Li N, Qu Y, Gai F, Zhang G and Zhang G: Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis. Exp Ther Med 12: 297-301, 2016.
APA
Li, Z., Li, N., Qu, Y., Gai, F., Zhang, G., & Zhang, G. (2016). Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis. Experimental and Therapeutic Medicine, 12, 297-301. https://doi.org/10.3892/etm.2016.3318
MLA
Li, Z., Li, N., Qu, Y., Gai, F., Zhang, G., Zhang, G."Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis". Experimental and Therapeutic Medicine 12.1 (2016): 297-301.
Chicago
Li, Z., Li, N., Qu, Y., Gai, F., Zhang, G., Zhang, G."Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis". Experimental and Therapeutic Medicine 12, no. 1 (2016): 297-301. https://doi.org/10.3892/etm.2016.3318
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team